These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21933309)

  • 1. Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
    Foley JH; Nesheim ME; Rivard GE; Brummel-Ziedins KE
    Haemophilia; 2012 May; 18(3):e316-22. PubMed ID: 21933309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A.
    Semeraro F; Mancuso ME; Ammollo CT; Dirienzo L; Vitulli A; Santagostino E; Tripodi A; Colucci M
    J Thromb Haemost; 2020 Feb; 18(2):381-389. PubMed ID: 31571361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor.
    Foley JH; Nesheim ME
    J Thromb Haemost; 2009 Mar; 7(3):453-9. PubMed ID: 19087221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO
    J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
    Colucci M; Incampo F; Cannavò A; Menegatti M; Siboni SM; Zaccaria F; Semeraro N; Peyvandi F
    J Thromb Haemost; 2016 Aug; 14(8):1603-14. PubMed ID: 27094709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?
    Antovic JP; Schulman S; An SS; Greenfield RS; Blombäck M
    Scand J Clin Lab Invest; 2004; 64(8):745-51. PubMed ID: 15719893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A.
    Antovic J; Schulman S; Eelde A; Blombäck M
    Haemophilia; 2001 Nov; 7(6):557-60. PubMed ID: 11851753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.
    Incampo F; Carrieri C; Galasso R; Scaraggi FA; Di Serio F; Woodhams B; Semeraro N; Colucci M
    J Thromb Haemost; 2013 Feb; 11(2):315-24. PubMed ID: 23256818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding.
    Wyseure T; Cooke EJ; Declerck PJ; Behrendt N; Meijers JCM; von Drygalski A; Mosnier LO
    Blood; 2018 Oct; 132(15):1593-1603. PubMed ID: 30026184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
    Zhou X; Declerck PJ
    J Thromb Haemost; 2015 Jun; 13(6):1084-9. PubMed ID: 25773535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P; Heylen E; Willemse J; Djordjević V; Radojković D; Colović M; Elezović I; Hendriks D
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T; Marquart JA; Marx PF; Meijers JC
    J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.
    Mikovic D; Woodhams BJ; Holmström M; Elezovic I; Antovic A; Mobarrez F; Elfvinge P; Antovic JP
    Int J Lab Hematol; 2012 Feb; 34(1):35-40. PubMed ID: 21707936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
    Antovic JP; Antovic A; He S; Tengborn L; Blombäck M
    Haemophilia; 2002 Nov; 8(6):781-6. PubMed ID: 12410647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of zinc ions in activation and inactivation of thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Bouma BN; Meijers JC
    Biochemistry; 2002 Jan; 41(4):1211-6. PubMed ID: 11802720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis.
    Bajzar L; Jain N; Wang P; Walker JB
    Crit Care Med; 2004 May; 32(5 Suppl):S320-4. PubMed ID: 15118538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into thrombin activatable fibrinolysis inhibitor function and regulation.
    Foley JH; Kim PY; Mutch NJ; Gils A
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():306-15. PubMed ID: 23809134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.